EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS AND MYASTHENIA GRAVIS: BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS *

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1976-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.1976.tb47691.xPMID 1066988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody to acetylcholine receptor in myasthenia gravis

  1976cited by this paper
• END‐PLATE POTENTIALS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IN RATS *

  1976cited by this paper
• Immunological studies of acetylcholine receptors.

  1976cited by this paper
• EXPERIMENTAL AUTOIMMUNE MYASTHENIA: CLINICAL, NEUROPHYSIOLOGIC, AND PHARMACOLOGIC ASPECTS *

  1976cited by this paper
• EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS: CELLULAR AND HUMORAL IMMUNE RESPONSES *

  1976cited by this paper
• THE MOTOR END PLATE IN MYASTHENIA GRAVIS AND IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS. A QUANTITATIVE ULTRASTRUCTURAL STUDY *

  1976cited by this paper
• CHAPTER XI – Isolated Single Electroplax Preparation

  1975cited by this paper
• Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor

  1975cited by this paper
• Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

  1975cited by this paper
• Blockade of acetylcholine receptors: a model of myasthenia gravis.

  1975cited by this paper
• Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.

  1975cited by this paper
• An acetylcholine receptor preparation lacking the 42,000 Dalton component.

  1975cited by this paper
• Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.

  1975cited by this paper
• Neurophysiological signs of myasthenia in rabbits after receptor antibody development.

  1975cited by this paper
• Structural stability and composition of acetylcholinesterase purified by affinity chromatography from fresh electroplax tissue of Electrophorus electricus.

  1975cited by this paper
• MYASTHENIA GRAVIS: A SERUM FACTOR BLOCKING ACETYLCHOLINE RECEPTORS OF THE HUMAN NEUROMUSCULAR JUNCTION

  1975cited by this paper
• Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

  1974cited by this paper
• Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine Receptors

  1974cited by this paper
• Purification and properties of the cholinergic receptor protein from Electrophorus electricus electric tissue.

  1974cited by this paper
• Purified acetylcholine receptor: its reconstitution to a chemically excitable membrane.

  1974cited by this paper
• Purification and characterization of acetylcholine receptor-I from Electrophorus electricus.

  1974cited by this paper
• The reactions of sodium and potassium ion-activated adenosine triphosphatase with specific antibodies. Implications for the mechanism of active transport.

  1974cited by this paper
• The nicotinic cholinergic receptor protein: improved purification method, preliminary amino acid composition and observed auto‐immuno response

  1974cited by this paper
• Autoimmune Response to Acetylcholine Receptor

  1973cited by this paper
• Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody.

  1973cited by this paper
• Molecular weight and quaternary structure of the cholinergic receptor protein extracted by detergents from Electrophorus electricus electric tissue

  1973cited by this paper
• Molecular properties of the cholinergic receptor purified from Electrophorus electricus.

  1973cited by this paper
• The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus.

  1973cited by this paper
• Immunological characterisation of the cholinergic receptor protein from Electrophorus electricus.

  1973cited by this paper
• Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

  1973cited by this paper
• A simple assay for the study of solubilized acetylcholine receptors.

  1973cited by this paper
• The affinity-labeling of partially purified acetylcholine receptor from electric tissue of Electrophorus.

  1973cited by this paper
• Chromatographic separation of the venom of Bungarus multicinctus and characterization of its components.

  1972cited by this paper
• Essential Chemical Requirements for Induction of Allergic Encephalomyelitis

  1971cited by this paper
• Isolation of the principal neurotoxins of two Naja naja subspecies.

  1971cited by this paper
• Immunopharmacological disease: a break in tolerance to receptor sites.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Myasthenia Gravis: A New Hypothesis

  1960cited by this paper
• An isolated single electroplax preparation. I. New data on the effect of acetylcholine and related compounds.

  1957cited by this paper
• Myasthenia gravis

  1955cited by this paper

• Hock immunization: a refined alternative for developing Experimental Autoimmune Myasthenia Gravis (EAMG) in mice

  2025cites this paper
• Hock immunization, a refined alternative for developing experimental autoimmune myasthenia gravis (EAMG) in mice

  2025cites this paper
• Myasthenia gravis-Pathophysiology, diagnosis, and treatment.

  2024cites this paper
• The muscle cell

  2020cites this paper
• Significance of Autoantibodies

  2019cites this paper
• GravisExperimental Autoimmune Myasthenia Antigen-Specific Immunotherapeutic Vaccine

  2017cites this paper
• История исследования миастении -от описания симптомов до изучения патогенеза

  2015cites this paper
• AChR-specific immunosuppressive therapy of myasthenia gravis.

  2015cites this paper
• Antigen-Specific Immunotherapeutic Vaccine for Experimental Autoimmune Myasthenia Gravis

  2014cites this paper
• Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.

  2014cites this paper
• Autoantibodies to Agrin in Myasthenia Gravis Patients

  2014cites this paper
• Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors

  2012cites this paper
• Myasthenia Gravis

  2012cites this paper
• Myasthenogenicity of the main immunogenic region

  2012cites this paper
• Diseases of the Neuromuscular Junction

  2012cites this paper
• Autoimmune Encephalopathies and Epilepsies in Children and Teenagers

  2012cites this paper
• Characterization of thymic hyperplasia associated with autoimmune Myasthenia Gravis : role of the chemokines CXCL12 and CXCL13

  2011cites this paper
• PRECLINICAL STUDIES OF PIXANTRONE AS IMMUNOSUPPRESSIVE DRUG IN THE ANIMAL MODEL OF MYASTHENIA GRAVIS

  2011influential citation
• Specific immunotherapy of experimental myasthenia gravis by a novel mechanism

  2010cites this paper
• The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies

  2008cites this paper
• Treatment of Myasthenia Gravis by Preventing Acetylcholine Receptor Modulation

  2008cites this paper
• Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.

  2007cites this paper
• [Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase].

  2006cites this paper
• Induction of myasthenia by immunization against muscle-specific kinase.

  2006cites this paper
• Myasthénie auto-immune et grossesse : évolution clinique, accouchement et post-partum

  2006cites this paper
• Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.

  2005cites this paper
• ALTERATIONS IN THE THYMOPOIESIS IN EXPERIMENTAL AUTOIMMUNE

  2005cites this paper
• Myasthenia Gravis " Or the Autoimmunity , Thymic Disease , Neuromuscular Block Poser MYASTHENIA

  2005cites this paper
• Immunopathology of acetylcholine receptors in myasthenia gravis

  2005cites this paper
• ALTERATIONS IN THE THYMOPOIESIS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS

  2005cites this paper
• Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model

  2005cites this paper
• Treatment review and update for myasthenia gravis.

  2004cites this paper
• Neuromuscular Disease and Its Complications

  2003cites this paper
• Pharmacokinetic–Pharmacodynamic Modeling of Rocuronium in Case of a Decreased Number of Acetylcholine Receptors: A Study in Myasthenic Pigs

  2003cites this paper
• Acetylcholine Receptor Structure

  2003cites this paper
• Construction and Characterization of a Single-chain Antibody Fragment Derived from Thymus of a Patient with Myasthenia Gravis

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type‐2 and type‐1 immune‐mediated diseases

  2001cites this paper
• Neuromuscular interaction of sevoflurane — cisatracurium in a myasthenic patient

  2000cites this paper
• Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models.

  1999cites this paper
• Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression.

  1999cites this paper
• Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.

  1999cites this paper
• Response in Rats Polarized Th 1-or Th 2-Type Immune Gravis May Occur in the Context of a Experimental Autoimmune Myasthenia

  1999cites this paper
• Cisatracurium in a myas- thenic patient undergo- ing thymectomy

  1999cites this paper
• Cisatracurium in a myasthénic patient undergoing thymectomy

  1999cites this paper
• An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.

  1998cites this paper
• Strategies for Inhibition of Complement Activation in the Treatment of Neurodegenerative Diseases

  1998cites this paper
• Anatomy of the antigenic structure of a large memberane autoantigen, the muscle‐type nicotinic acetylcholine receptor

  1998cites this paper
• Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis.

  1998cites this paper
• Nicotinic Acetylcholine Receptors of Muscle and Neuronal (α7) Types Coexpressed in a Small Cell Lung Carcinoma

  1997cites this paper
• Age‐related susceptibility to experimental autoimmune myasthenia gravis: Immunological and electrophysiological aspects

  1997cites this paper
• Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG.

  1997cites this paper
• Age‐ and sex‐related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats

  1997cites this paper
• Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma.

  1997cites this paper
• Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.

  1996cites this paper
• Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response

  1996cites this paper
• Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis.

  1995cites this paper
• Immunological factors that influence disease severity in experimental autoimmune myasthenia gravis

  1994cites this paper
• Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.

  1994cites this paper
• Development of alpha-neurotoxin antibodies in patients envenomed by the monocellate Thai cobra (Naja kaouthia).

  1994cites this paper
• Ocular myasthenia: a protean disorder.

  1994cites this paper
• Experimental Autoimmune Myasthenia Gravis

  1994cites this paper
• Nicotinic acetylcholine receptor: structure, function and main immunogenic region.

  1994cites this paper
• Nine Residues Influence the Binding of α‐Bungarotoxin in α‐Subunit Region 185–200 of Human Muscle Acetylcholine Receptor

  1993cites this paper
• Myasthenia gravis.

  1993cites this paper
• Nine residues influence the binding of alpha-bungarotoxin in alpha-subunit region 185-200 of human muscle acetylcholine receptor.

  1993cites this paper
• Influence of Immunological Fine‐specificity on the Induction of Experimental Myasthenia Gravis a

  1993cites this paper
• Pediatric Neuromuscular Emergencies

  1993cites this paper
• Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.

  1992cites this paper
• In vivo neurotoxin administration alters immune responses in chickens (Gallus domesticus).

  1992cites this paper
• Guillain-Barré Syndrome and Myasthenia Gravis

  1992cites this paper
• Human myasthenia gravis thymic myoid cells: de novo immunohistochemical and intracellular electrophysiological studies.

  1991cites this paper
• Myasthenia gravis, muscle twitch, hyperhidrosis and limb pain associated with thymoma: proposal of possible new myasthenic syndrome.

  1991cites this paper
• Tissue monoamine and plasma corticosterone concentrations following sympathetic alteration during acute endotoxicosis in chickens.

  1991cites this paper
• A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.

  1991cites this paper
• The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.

  1991cites this paper
• Action of anticholinergic receptor antibodies on the frog heart

  1991cites this paper
• Splenectomy in the treatment of severe forms of myasthenia

  1991cites this paper
• The thymus in seronegative myasthenia gravis patients

  1991cites this paper
• Alpha-bungarotoxin binds to human acetylcholine receptor alpha-subunit peptide 185-199 in solution and solid phase but not to peptides 125-147 and 389-409.

  1990cites this paper
• α‐Bungarotoxin Binds to Human Acetylcholine Receptor α‐Subunit Peptide 185–199 in Solution and Solid Phase but Not to Peptides 125–147 and 389–409

  1990cites this paper
• Diagnosis of Myasthenia Gravis in the 1990s

  1990cites this paper
• Psychoneuroimmunology: An area of interest for the psychopharmacologist?

  1990cites this paper
• Myasthenia gravis.

  1990cites this paper
• Stress and the Immune System: Immunological Aspects of Depressive Illness

  1990cites this paper
• Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen.

  1989cites this paper
• On the development of behavioral tolerance to organophosphates. I: Behavioral and biochemical aspects.

  1989cites this paper
• High‐Dose Immunoglobulin for Juvenile Myasthenia Gravis

  1989cites this paper
• Experimental autoimmune myasthenia gravis induced in mice without adjuvant: genetic susceptibility and adoptive transfer of weakness.

  1989cites this paper
• Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis

  1989cites this paper
• Role of the macrophage in the pathogenesis of experimental autoimmune myasthenia gravis.

  1988cites this paper
• Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis

  1988cites this paper
• Anti-Acetylcholine Receptor Antibody in Myasthenia Gravis : Relationship to Disease Severity and Effect of Thymectomy.

  1988cites this paper
• Isolation and characterization of nicotinic acetylcholine receptor-like protein from fetal calf thymus.

  1988cites this paper
• Anti-Acetylcholine Receptor Antibody in Myasthenia Gravis

  1987cites this paper
• The Role of the Thymus in Myasthenia Gravis: Immunohistological and Immunological Studies in 115 Cases a

  1987cites this paper
• Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravis a

  1987cites this paper
• Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study

  1987cites this paper
• Serum Antibodies and Monoclonal Antibodies Secreted by Thymic B‐Cell Clones from Patients with Myasthenia Gravis Define Striational Antigens a

  1987cites this paper
• Human × Human Hybridomas from Patients with Myasthenia Gravis: Possible Tools for Idiotypic Therapy for Myasthenia a

  1987cites this paper